TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11497197

Group type: EXPERIMENTAL
Intervention: High pulse pressure (PP)
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP), pulse pressure (PP), and mean arterial pressure (MAP)
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure (DBP)
Number of subjects: 4736

Group type: EXPERIMENTAL
Intervention: Pulse pressure (PP)
Number of subjects: 4736
Study: 9510100

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) treatment with fluences ranging from 3-6.5 J/cm2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) treatment
Number of subjects: 15
Study: 8296738

Group type: EXPERIMENTAL
Intervention: Home exercise training program using wheelchair ergometry
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual and customary care (Control)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Both groups (Home exercise training and Control)
Number of subjects: 88
Study: 2566879

Group type: EXPERIMENTAL
Intervention: Cetirizine (20 mg QD for 2 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30572482

Group type: EXPERIMENTAL
Intervention: Baduanjin training combined with CBT
Number of subjects: 120

Group type: COMPARATOR
Intervention: Baduanjin training
Number of subjects: 120

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 120
Study: 27464582

Group type: EXPERIMENTAL
Intervention: S-1226 (4%, 8%, or 12% CO2) administered by nebulization over a 2-minute period
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo administered by nebulization over a 2-minute period
Number of subjects: 36
Study: 23777653

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall compression (HFCWC) therapy
Number of subjects: 22
Study: 21733334

Group type: EXPERIMENTAL
Intervention: High-protein and low-glycaemic index diet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-protein and high-glycaemic index diet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 96
Study: 21079179

Group type: EXPERIMENTAL
Intervention: Modafinil (100-200 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18772858

Group type: EXPERIMENTAL
Intervention: 10% glucose water
Number of subjects: 15

Group type: COMPARATOR
Intervention: water
Number of subjects: 15
Study: 15189750

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Biphasic insulin lispro 25 (Mix25)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 133

Group type: COMPARATOR
Intervention: Mix25
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: FlexPen
Number of subjects: 133

Group type: COMPARATOR
Intervention: Humalog Pen
Number of subjects: 133
Study: 11689745

Group type: EXPERIMENTAL
Intervention: Aerobic training (interval training, four times 4 min at 90‐95% of maximal heart rate, with a 3‐min jog in between, twice per week for 8 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 9730298

Group type: EXPERIMENTAL
Intervention: Serum soluble CD23 levels in lepromatous leprosy (LL)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Serum soluble CD23 levels in tuberculoid leprosy (TL)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Serum soluble CD23 levels in healthy controls
Number of subjects: 2
Study: 7987090

Group type: COMPARATOR
Intervention: Zidovudine prophylaxis (oral from 14th gestational week and intravenous during delivery)
Number of subjects: 0
Study: 2738979

Group type: EXPERIMENTAL
Intervention: Tubing changed every 24 hours
Number of subjects: 101

Group type: COMPARATOR
Intervention: Tubing changed every 48 hours
Number of subjects: 101
Study: 31735521

Group type: EXPERIMENTAL
Intervention: Colocystoplasty (CCP)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Gastrocystoplasty (GCP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (no malignancy)
Number of subjects: 35
Study: 29722947

Group type: EXPERIMENTAL
Intervention: Nursing care intervention including knowledge, skills, diet, exercise, medication, and psychology through one-to-one consultation, individualized or group communication, establishing files, telephone follow-up, and WeChat guidance.
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (standard care without nursing intervention).
Number of subjects: 600
Study: 25846251

Group type: EXPERIMENTAL
Intervention: Integrated cognitive-behavioral therapy (ICBT) plus standard care (SC)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Individual addiction counseling (IAC) plus standard care (SC)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Integrated cognitive-behavioral therapy (ICBT)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Individual addiction counseling (IAC)
Number of subjects: 221
Study: 23331240

Group type: EXPERIMENTAL
Intervention: Triple antibiotic paste (TAP)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste [Ca(OH)₂]
Number of subjects: 180

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 180
Study: 21883952

Group type: COMPARATOR
Intervention: Pelvic floor ultrasound assessment of ARA at rest
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pelvic floor ultrasound assessment of ARA during contraction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pelvic floor ultrasound assessment of LPA at rest
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pelvic floor ultrasound assessment of LPA during contraction
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pelvic floor ultrasound assessment of LPA excursion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correlation of ARA with pain report
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correlation of ARA with sexual dysfunction
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correlation of anxiety with ARA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Correlation of anxiety with LPA
Number of subjects: 24
Study: 19929251

Group type: EXPERIMENTAL
Intervention: Palonosetron in combination with dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: First generation 5-HT3 receptor antagonists
Number of subjects: 0
Study: 17044900

Group type: EXPERIMENTAL
Intervention: Oral baclofen
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15611807

Group type: EXPERIMENTAL
Intervention: Symptom resolution in patients with Mycoplasma pneumoniae pneumonia
Number of subjects: 76
Study: 10770746

Group type: EXPERIMENTAL
Intervention: Virosome vaccine (0.5 ml on study day 0 or 0.25 ml on days 0 and 28)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Subunit vaccine (0.5 ml on day 0 for older children and 0.25 ml on days 0 and 28 for younger children)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Virosome vaccine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Subunit vaccine
Number of subjects: 64
Study: 9311548

Group type: EXPERIMENTAL
Intervention: Zinc phosphide exposure
Number of subjects: 86
Study: 8325315

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 21
Study: 3539171

Group type: EXPERIMENTAL
Intervention: 30 mg etretinate daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29415824

Group type: EXPERIMENTAL
Intervention: 3-dimensional virtual reconstruction and volumetric analysis of control volume segments
Number of subjects: 20
Study: 26960060

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 516

Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Isavuconazole (moderate-to-severe renal impairment)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Voriconazole (moderate-to-severe renal impairment)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Isavuconazole (BMI ≥30 kg/m²)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Voriconazole (BMI ≥30 kg/m²)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Isavuconazole (age >65 years)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Voriconazole (age >65 years)
Number of subjects: 516
Study: 24903987

Group type: EXPERIMENTAL
Intervention: Right ventricular mid-septal pacing (RVMSP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Right ventricular apical pacing (RVAP)
Number of subjects: 92
Study: 22323712

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) applied to trained V1 location within 45 min of training sessions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training in the location targeted by TMS followed by training in a second location before TMS.
Number of subjects: 0
Study: 20180695

Group type: EXPERIMENTAL
Intervention: 500 mg of dried modified Saccharomyces cerevisiae oral fermentate (EpiCor)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 19127914

Group type: EXPERIMENTAL
Intervention: Tongdu Tiaojin needling method
Number of subjects: 58

Group type: COMPARATOR
Intervention: Routine acupuncture method
Number of subjects: 58
Study: 15249749

Group type: EXPERIMENTAL
Intervention: Mistletoe treatment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional oncology studies
Number of subjects: 74
Study: 11522552

Group type: EXPERIMENTAL
Intervention: Abstention from coffee for 6 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: 1-3 cups of coffee (175-525 mL/d) for 6 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: 4 cups of coffee (700 mL/d) for 6 weeks
Number of subjects: 191
Study: 9296422

Group type: EXPERIMENTAL
Intervention: Isoproterenol 1 microg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isoproterenol 2 microg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isoproterenol 3 microg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isoproterenol (all doses)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isoproterenol (3 microg)
Number of subjects: 45
Study: 8299597

Group type: EXPERIMENTAL
Intervention: High CHO diet (83% of energy intake as CHO)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moderate CHO diet (58% of energy intake as CHO)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low CHO diet (12% of energy intake as CHO)
Number of subjects: 14
Study: 30777508

Group type: EXPERIMENTAL
Intervention: Cantonese-accented words presented auditorily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory presentation of accented words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lengthened interstimulus intervals in accented word recall (Experiment 2)
Number of subjects: 0
Study: 27792212

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Femoral nerve block with dexamethasone (FNB+Dexa)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Femoral nerve block with dexmedetomidine (FNB+Dexm)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Adductor canal block with dexamethasone (ACB+Dexa)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Adductor canal block with dexmedetomidine (ACB+Dexm)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 639
Study: 26897374

Group type: EXPERIMENTAL
Intervention: Pulsed Electric Field (PEF) treatment at 15 kV/cm and 100 mL/min flow velocity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulsed Electric Field (PEF) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated α-amylase)
Number of subjects: 0
Study: 25052847

Group type: COMPARATOR
Intervention: Amitriptyline (25 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg) + Amitriptyline (25 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Melatonin + Amitriptyline
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 63
Study: 22033534

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (LHTL group, n = 10)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal air (placebo group, n = 6)
Number of subjects: 16
Study: 19535710

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study: 17659464

Group type: EXPERIMENTAL
Intervention: HIIC (mitomycin C 30 mg and cisplatin 100 mg in 2000 ml distilled water, heated to 42-45 degrees C, perfused for 30 min) and intravenous chemotherapy (5-FU 10-15 mg/kg, mitomycin C 0.1-0.15 mg/kg, adriamycin 0.5-1 mg/kg i.v drip, once a week for 2-3 weeks)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Intravenous chemotherapy only (control group)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: HIIC
Number of subjects: 212
Study: 15219642

Group type: EXPERIMENTAL
Intervention: Primary insomnia patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 29
Study: 10708177

Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nadroparin and Dalteparin
Number of subjects: 32
Study: 9236673

Group type: EXPERIMENTAL
Intervention: cA2 therapy (1 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cA2 therapy (10 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cA2 therapy (1 mg/kg and 10 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cA2 therapy
Number of subjects: 0
Study: 8370794

Group type: EXPERIMENTAL
Intervention: Women-only group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Couples-only group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 57
Study: 3531924

Group type: EXPERIMENTAL
Intervention: O‐(beta‐hydroxyethyl)‐rutosides (4 g/day orally)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31736356

Group type: EXPERIMENTAL
Intervention: Self-Expanding Transcatheter Heart Valve (SE-THV)
Number of subjects: 3910

Group type: COMPARATOR
Intervention: Balloon-Expandable Transcatheter Heart Valve (BE-THV)
Number of subjects: 3910
Study: 28891824

Group type: EXPERIMENTAL
Intervention: Low FODMAP (LFOD) diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: High FODMAP (HFOD) diet
Number of subjects: 11
Study: 28477684

Group type: EXPERIMENTAL
Intervention: Baseline history of falls
Number of subjects: 1741

Group type: COMPARATOR
Intervention: Men vs Women
Number of subjects: 1741

Group type: EXPERIMENTAL
Intervention: UPDRS Activities of Daily Living (ADL) score
Number of subjects: 1741

Group type: EXPERIMENTAL
Intervention: Total functional capacity (TFC)
Number of subjects: 1741

Group type: EXPERIMENTAL
Intervention: Baseline ambulatory capacity score
Number of subjects: 1741

Group type: EXPERIMENTAL
Intervention: Dopamine agonist monotherapy
Number of subjects: 1741
Study: 26362000

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 151
Study: 23444107

Group type: EXPERIMENTAL
Intervention: Contingent capture during attentional blink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concurrent task demands
Number of subjects: 0
Study: 21382512

Group type: EXPERIMENTAL
Intervention: 1% C31G or SAVVY®
Number of subjects: 7086

Group type: EXPERIMENTAL
Intervention: 6% cellulose sulfate or CS
Number of subjects: 7086

Group type: COMPARATOR
Intervention: Baseline factors associated with non-retention
Number of subjects: 7086
Study: 18996868

Group type: EXPERIMENTAL
Intervention: Whey protein supplement (40 g whey protein, 280 kcal, twice daily for 12 weeks)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control supplement (matched isocaloric supplement without added protein, twice daily for 12 weeks)
Number of subjects: 59
Study: 16842920

Group type: EXPERIMENTAL
Intervention: Bradykinin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Substance P
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Serotonin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Antihistamine (olopatadine hydrochloride)
Number of subjects: 29
Study: 12671528

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg daily in addition to perphenazine (8 mg/day or 16 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Perphenazine (8 mg/day or 16 mg/day)
Number of subjects: 12
Study: 10902982

Group type: EXPERIMENTAL
Intervention: Condensed milk + micronutrients
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Skimmed milk + micronutrients
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Skimmed milk
Number of subjects: 156
Study: 9373659

Group type: EXPERIMENTAL
Intervention: 15% paromomycin (aminosidine) and 10% urea in white paraffin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 1542491

Group type: EXPERIMENTAL
Intervention: Continuous intravenous 5-fluorouracil (5-FU) at a dose of 650 mg/m2 per day for 7 consecutive days, escalated in subsequent cycles
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Continuous intravenous 5-fluorouracil (5-FU)
Number of subjects: 38
Study: 31221565

Group type: EXPERIMENTAL
Intervention: Topical nepafenac 0.3%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pressure patching for 2 hours
Number of subjects: 60

Group type: COMPARATOR
Intervention: Preservative-free artificial tears (control group)
Number of subjects: 60
Study: 28045585

Group type: EXPERIMENTAL
Intervention: Zagreb regimen
Number of subjects: 114

Group type: COMPARATOR
Intervention: Essen regimen
Number of subjects: 114
Study: 27561822

Group type: EXPERIMENTAL
Intervention: Web-enhanced telephone health coaching intervention (IGR3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone-only health coaching intervention (IGR2)
Number of subjects: 0
Study: 24939313

Group type: EXPERIMENTAL
Intervention: Psychological intervention (mailing knowledge manual, face-to-face counseling, telephone counseling)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Conventional methods (control group)
Number of subjects: 771

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 771
Study: 22435986

Group type: EXPERIMENTAL
Intervention: Distraction using Flippits® cards
Number of subjects: 123

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 123
Study: 19050620

Group type: EXPERIMENTAL
Intervention: Preoxygenation for 4 mins with 100% oxygen
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Preoxygenation for 6 mins with 100% oxygen
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Preoxygenation for 8 mins with 100% oxygen
Number of subjects: 34
Study: 18444818

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPnC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7vPnC/7vPnC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7vPnC/PPV
Number of subjects: 0

Group type: COMPARATOR
Intervention: PPV/7vPnC
Number of subjects: 0
Study: 16196295

Group type: EXPERIMENTAL
Intervention: Enteral diet supplemented with glutamine, arginine and omega‐3‐fatty acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard enteral nutrition
Number of subjects: 40
Study: 12537922

Group type: EXPERIMENTAL
Intervention: Telemedicine service
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 74
Study: 10418768

Group type: EXPERIMENTAL
Intervention: Calloused sexual beliefs (CSB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Noncoercive men
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Coercive men low in CSB
Number of subjects: 100

Group type: COMPARATOR
Intervention: Token resistance manipulation
Number of subjects: 100
Study: 7653320

Group type: EXPERIMENTAL
Intervention: Counselor alliance
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Peer alliance
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both counselor and peer alliance
Number of subjects: 41

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 41
Study: 2286600

Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-and-see approach (control)
Number of subjects: 0
Study: 6169578

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 50
Study: 31776278

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed boosting with AIDSVAX B/E
Number of subjects: 0
Study: 29863966

Group type: EXPERIMENTAL
Intervention: False-positive feedback
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: False-negative feedback
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: False-neutral feedback
Number of subjects: 15
Study: 28258636

Group type: EXPERIMENTAL
Intervention: Clip attachments (CR group, n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resilient liner attachments (RR group, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (CR and RR)
Number of subjects: 30
Study: 25821959

Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplementation
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Zinc plus iron-folic acid supplementation
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 569
Study: 23953282

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus hyaluronidase (75 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lidocaine with epinephrine (placebo)
Number of subjects: 40
Study: 21658240

Group type: EXPERIMENTAL
Intervention: EPA/GLA diet
Number of subjects: 115